A
Avidity Biosciences, Inc. (RNA)
NMS – Real Time Price. Currency in USD
13.19
+0.41 (3.21%)
At close: Jun 26, 2026, 4:00 PM EDT
13.19
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
13.19
+0.41 (3.21%)
At close: Jun 26, 2026, 4:00 PM EDT
13.19
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $267.8M significantly exceed its total debt $2.7M, ensuring strong financial flexibility
Total current assets $285.6M exceed Total current liabilities $21.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$33.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.04 | 6.05 | 10 | |
| Quick ratio | 13.04 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Total Revenue | 10M | 11M | 19M | 25M |
| Gross Profit | 10M | 11M | 18M | 25M |
| Operating Income | -6M | -13M | -50M | -60M |
| Net Income | -6M | -25M | -50M | -65M |
| EBITDA | -6M | -13M | -49M | -60M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | 16.13 | -4.84 | 5.0 |
| Next year | -87.65 | -19.45 | 1.0 |
| Weighted average score | 2.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 2185.8 | 42.91 | -59.01 | N/A | 5.5 |
| Y/Y | N/A | N/A | N/A | N/A | 1.0 |
| 3y average | N/A | N/A | N/A | N/A | 1.0 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Medium | 5.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 3.0 |
| Weighted average score | 3.6 | |